Mepro Pharmaceuticals Private Limited

Mepro Pharmaceuticals Private Limited - pharma in Surendra Nagar, Gujarat, India. FY 2026 financials and compliance.
CIN U24231GJ1982PTC005451 Incorporated 31 August 1982 ROC Ahmedabad HQ Surendra Nagar, Gujarat, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹356.46 Cr
▲ 20.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹5.4 Cr
Registered with MCA
Paid-up capital
₹5.35 Cr
Issued & subscribed
Open charges
₹169.2 Cr
Satisfied ₹12.5 Cr
Company age
44 yrs
Est. 1982
Employees · EPFO
543
Latest available

About Mepro Pharmaceuticals Private Limited

Data last updated: 18 March 2026

Mepro Pharmaceuticals Private Limited is a private limited company based in Surendra Nagar, Gujarat, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 31 August 1982, the company has been in operation for over 44 years.

Registered with ROC Ahmedabad under CIN U24231GJ1982PTC005451.

Capital: an authorised share capital of ₹5.4 Cr and a paid-up capital of ₹5.35 Cr. It is led by directors including Prakash Navinchandra Shah and Bharatkumar Chabildas Shah.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 1003 – Gidc Wadhwan, Surendra Nagar, Gujarat, India – 363035.

As per the financials filed for FY 2025, the company reported a revenue of ₹356.46 Cr, a growth of 20% compared to the previous year.

The company has a workforce of approximately 543 employees as per the latest available data.

The company is associated with 1 brand - Mepro. As per MCA filings, the company has open charges of ₹169.2 Cr and satisfied charges of ₹12.5 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mepro.in.

Company Details of Mepro Pharmaceuticals Private Limited
CIN U24231GJ1982PTC005451
Registration Number 005451
Incorporation Date 31 August 1982
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
    Locked
  • Registered Address
    1003 – Gidc Wadhwan, Surendra Nagar, Gujarat, India – 363035
  • Industry
    Pharma, Drug Formulation & Development
Company report
Mepro Pharmaceuticals Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Mepro Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Mepro Pharmaceuticals Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Mepro Pharmaceuticals Private Limited

Mepro Pharmaceuticals Private Limited operates one associated brand: Mepro. These brands represent Mepro Pharmaceuticals Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Manufacturing and exporting of pharmaceuticals is conducted by Mepro globally. mepro.in

Business Activity of Mepro Pharmaceuticals Private Limited

Mepro Pharmaceuticals Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Mepro Pharmaceuticals Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Mepro Pharmaceuticals Private Limited

Mepro Pharmaceuticals Private Limited is audited by Ankush Gupta & Associates for the financial year 2025. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
Ankush Gupta & Associates Locked Locked Locked
Premium access

Complete auditor history for Mepro Pharmaceuticals Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Mepro Pharmaceuticals Private Limited

Mepro Pharmaceuticals Private Limited is currently managed by 5 directors, with 8 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Prakash Navinchandra Shah Director 17 Jul 2004 22 Years 0 Months Current
Bharatkumar Chabildas Shah Director 31 Aug 1982 43 Years 10 Months Current
Suresh Chhabildas Shah Director 31 Aug 1982 43 Years 10 Months Current
Vijay Chhabildas Shah Whole-Time Director 31 Aug 1982 43 Years 10 Months Current
Rajesh Sumanlal Shah Director 30 Sep 1987 38 Years 9 Months Current

Financials of Mepro Pharmaceuticals Private Limited FY 2025 filings available

Mepro Pharmaceuticals Private Limited reported revenue of ₹356.46 Cr (up 20.00% YoY) for FY 2025.

Revenue · FY 2025
₹356.46 Cr ▲ 20.00%
Premium access

Ten-year financial statements for Mepro Pharmaceuticals Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Mepro Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data for Mepro Pharmaceuticals Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Mepro Pharmaceuticals Private Limited

Open charges
₹169.2 Cr
Satisfied charges
₹12.5 Cr
Breakdown by lending institutions
Others₹110.70 Cr
Yes Bank Limited₹58.50 Cr
Latest charge details
DateLenderAmountStatus
05 Dec 2022 Others ₹5 Cr Open
17 Oct 2019 Others ₹38.5 Cr Open
17 Oct 2019 Yes Bank Limited ₹10 Cr Open
21 May 2019 Yes Bank Limited ₹10 Cr Open
21 May 2019 Yes Bank Limited ₹38.5 Cr Open

Total charge records: 11 View all charges

Employees and EPFO Compliance at Mepro Pharmaceuticals Private Limited

Mepro Pharmaceuticals Private Limited has a workforce of 543 employees as of Oct 10, 2025.

Employee count
543
Active EPFO establishments
1
Employee growth
5.23%
Premium access

Employee and EPFO history for Mepro Pharmaceuticals Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Mepro Pharmaceuticals Private Limited

Premium access

GST registrations and filing compliance for Mepro Pharmaceuticals Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Mepro Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Mepro Pharmaceuticals Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Mepro Pharmaceuticals Private Limited

Premium access

MSME payment history for Mepro Pharmaceuticals Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Mepro Pharmaceuticals Private Limited

Premium access

Corporate group structure for Mepro Pharmaceuticals Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Mepro Pharmaceuticals Private Limited

Premium access

MCA filings and documents for Mepro Pharmaceuticals Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Mepro Pharmaceuticals Private Limited

Activity
30 Sep 2025
Mepro Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Mepro Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
05 Dec 2022
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100668963 was registered on 05 Dec 2022.
Charges
21 Jul 2022
A charge with Yes Bank Limited of Rs. 10.00 Cr registered on 17 Oct 2019 with Charge ID 100300344 was modified on 21 Jul 2022.
Charges
23 Mar 2022
A charge with Yes Bank Limited of Rs. 10.00 Cr registered on 21 May 2019 with Charge ID 100268524 was modified on 23 Mar 2022.
Charges
23 Mar 2022
A charge with Yes Bank Limited of Rs. 38.50 Cr registered on 21 May 2019 with Charge ID 100268529 was modified on 23 Mar 2022.

Frequently Asked Questions about Mepro Pharmaceuticals Private Limited

Mepro Pharmaceuticals Private Limited is an active private limited company in the pharma sector based in Surendra Nagar, Gujarat, India. It was incorporated on 31 August 1982 (44+ years old) and is registered under CIN U24231GJ1982PTC005451. The company has 543 employees.

Mepro Pharmaceuticals Private Limited reported revenue of ₹356.46 Cr for FY 2025 (up 20.00% YoY).

The current directors of Mepro Pharmaceuticals Private Limited are:

The primary industry of Mepro Pharmaceuticals Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Mepro Pharmaceuticals Private Limited can be reached at the registered office: 1003 – Gidc Wadhwan, Surendra Nagar, Gujarat, India – 363035, or through the website mepro.in.

The authorised capital is ₹5.4 Cr, and the paid-up capital is ₹5.35 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available